Quest Diagnostics Stock (NYSE: DGX) stock price, news, charts, stock research, profile.
Open | $131.180 |
Close | $133.110 |
Volume / Avg. | 888.001K / 1.030M |
Day Range | 131.180 - 133.410 |
52 Wk Range | 119.590 - 148.620 |
Market Cap | $14.736B |
P/E Ratio | 17.498 |
Dividend Yield | 2.290% |
Exchange | NYSE |
RSI | 66 |
Short Interest | 3.15% |
Days to Cover | 2.6 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Quest Diagnostics (NYSE: DGX) through any online brokerage.
Other companies in Quest Diagnostics’s space includes: CVS Health (NYSE:CVS), Chemed (NYSE:CHE), Agiliti (NYSE:AGTI), Hims & Hers Health (NYSE:HIMS) and Privia Health Gr (NASDAQ:PRVA).
The latest price target for Quest Diagnostics (NYSE: DGX) was reported by Truist Securities on Wednesday, March 20, 2024. The analyst firm set a price target for 145.00 expecting DGX to rise to within 12 months (a possible 8.93% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Quest Diagnostics (NYSE: DGX) is $133.11 last updated March 28, 2024 at 4:20 PM EDT.
The next Quest Diagnostics (DGX) dividend date is projected to be Friday, April 5, 2024.
Quest Diagnostics’s Q4 earnings are confirmed for Thursday, February 2, 2023.
There is no upcoming split for Quest Diagnostics.
Quest Diagnostics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.